Related references
Note: Only part of the references are listed.Anti-cancer effects of polyphenols via targeting p53 signaling pathway: updates and future directions
Haroon Khan et al.
BIOTECHNOLOGY ADVANCES (2020)
Resveratrol Promotes Mitochondrial Biogenesis and Protects against Seizure-Induced Neuronal Cell Damage in the Hippocampus Following Status Epilepticus by Activation of the PGC-1 Signaling Pathway
Yao-Chung Chuang et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
Binding of Plant Polyphenols to Serum Albumin and LDL: Healthy Implications for Heart Disease
Dana M. Poloni et al.
JOURNAL OF AGRICULTURAL AND FOOD CHEMISTRY (2019)
Naturally Lignan-Rich Foods: A Dietary Tool for Health Promotion?
Carmen Rodriguez-Garcia et al.
MOLECULES (2019)
Effect of Pterostilbene, a Natural Analog of Resveratrol, on the Activity of some Antiepileptic Drugs in the Acute Seizure Tests in Mice
Dorota Nieoczym et al.
NEUROTOXICITY RESEARCH (2019)
Application of quercetin in neurological disorders: from nutrition to nanomedicine
Elnaz Amanzadeh et al.
REVIEWS IN THE NEUROSCIENCES (2019)
(-)-Epigallocatechin-3-Gallate Protects Against Lithium-Pilocarpine-Induced Epilepsy by Inhibiting the Toll-Like Receptor 4 (TLR4)/Nuclear Factor-κB (NF-κB) Signaling Pathway
Zhenzhen Qu et al.
MEDICAL SCIENCE MONITOR (2019)
Nanosized Transferosome-Based Intranasal In Situ Gel for Brain Targeting of Resveratrol: Formulation, Optimization, In Vitro Evaluation, and In Vivo Pharmacokinetic Study
Heba F. Salem et al.
AAPS PHARMSCITECH (2019)
Polyphenols in the treatment of autoimmune diseases
Haroon Khan et al.
AUTOIMMUNITY REVIEWS (2019)
Dual-drug loaded nanoparticles of Epigallocatechin-3-gallate (EGCG)/Ascorbic acid enhance therapeutic efficacy of EGCG in a APPswe/PS1dE9 Alzheimer's disease mice model
Amanda Cano et al.
JOURNAL OF CONTROLLED RELEASE (2019)
Advances in the Antagonism of Epigallocatechin-3-gallate in the Treatment of Digestive Tract Tumors
Changwei Liu et al.
MOLECULES (2019)
TRPV4-induced inflammatory response is involved in neuronal death in pilocarpine model of temporal lobe epilepsy in mice
Zhouqing Wang et al.
CELL DEATH & DISEASE (2019)
A Selective Role of Dietary Anthocyanins and Flavan-3-ols in Reducing the Risk of Type 2 Diabetes Mellitus: A Review of Recent Evidence
Britt Burton-Freeman et al.
NUTRIENTS (2019)
Resveratrol Promotes Diabetic Wound Healing via SIRT1-FOXO1-c-Myc Signaling Pathway-Mediated Angiogenesis
Xiaozhong Huang et al.
FRONTIERS IN PHARMACOLOGY (2019)
Evaluation of IL-1 levels in epilepsy and traumatic brain injury in dogs
Draginja Kostic et al.
BMC NEUROSCIENCE (2019)
Inflammation and reactive oxygen species in status epilepticus: Biomarkers and implications for therapy
Gaetano Terrone et al.
EPILEPSY & BEHAVIOR (2019)
Cholate-modified polymer-lipid hybrid nanoparticles for oral delivery of quercetin to potentiate the antileukemic effect
Juntao Yin et al.
INTERNATIONAL JOURNAL OF NANOMEDICINE (2019)
Neuroinflammatory pathways as treatment targets and biomarkers in epilepsy
Annamaria Vezzani et al.
NATURE REVIEWS NEUROLOGY (2019)
Polyphenols: Immunomodulatory and Therapeutic Implication in Colorectal Cancer
Anna Maria Mileo et al.
FRONTIERS IN IMMUNOLOGY (2019)
Advances in the Potential Biomarkers of Epilepsy
Dominik Kobylarek et al.
FRONTIERS IN NEUROLOGY (2019)
Immune Profile in Blood Following Non-convulsive Epileptic Seizures in Rats
Una Avdic et al.
FRONTIERS IN NEUROLOGY (2019)
Polyphenol Microbial Metabolites Exhibit Gut and Blood-Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation
Shelby L. Johnson et al.
METABOLITES (2019)
An Efficient Synthesis of Deoxyrhapontigenin-3-O-β-D-glucuronide, a Brain-Targeted Derivative of Dietary Resveratrol, and Its Precursor 4′-O-Me-Resveratrol
Angelo de Fatima et al.
ACS OMEGA (2019)
Epileptogenesis-Associated Alterations of Heat Shock Protein 70 in a Rat Post-Status Epilepticus Model
Fabio Gualtieri et al.
NEUROSCIENCE (2019)
Galangin Prevents Increased Susceptibility to Pentylenetetrazol-Stimulated Seizures by Prostaglandin E2
Viviane Nogueira de Zorzi et al.
NEUROSCIENCE (2019)
A New Therapeutic Approach for Brain Delivery of Epigallocatechin Gallate: Development and Characterization Studies
Harjeet Kaur et al.
CURRENT DRUG DELIVERY (2019)
Neuroprotective effects of curcumin lipid-core nanocapsules in a model Alzheimer's disease induced by β-amyloid 1-42 peptide in aged female mice
Renata Giacomeli et al.
BRAIN RESEARCH (2019)
Targeting high-mobility group box protein 1 (HMGB1) in pediatric traumatic brain injury: Chronic neuroinflammatory, behavioral, and epileptogenic consequences
Kyria M. Webster et al.
EXPERIMENTAL NEUROLOGY (2019)
An update of cyclooxygenase (COX)-inhibitors in epilepsy disorders
Ashish Dhir
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2019)
Polyphenol Health Effects on Cardiovascular and Neurodegenerative Disorders: A Review and Meta-Analysis
Francesco Poti et al.
INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES (2019)
High mobility group box 1 (HMGB1) as a novel frontier in epileptogenesis: from pathogenesis to therapeutic approaches
Yam Nath Paudel et al.
JOURNAL OF NEUROCHEMISTRY (2019)
Resveratrol exerts a protective effect in chronic unpredictable mild stress-induced depressive-like behavior: involvement of the AKT/GSK3 signaling pathway in hippocampus
Jun Shen et al.
PSYCHOPHARMACOLOGY (2019)
Brain targeting of resveratrol by nasal administration of chitosan-coated lipid microparticles
Valentina Trotta et al.
EUROPEAN JOURNAL OF PHARMACEUTICS AND BIOPHARMACEUTICS (2018)
Flavonoid compounds as reversing agents of the P-glycoprotein-mediated multidrug resistance: An in vitro evaluation with focus on antiepileptic drugs
Ana Ferreira et al.
FOOD RESEARCH INTERNATIONAL (2018)
Effect of Resveratrol on Oxidative Stress and Mitochondrial Dysfunction in Immature Brain during Epileptogenesis
Jaroslava Folbergrova et al.
MOLECULAR NEUROBIOLOGY (2018)
Epigallocatechin-3-gallate loaded PEGylated-PLGA nanoparticles: A new anti-seizure strategy for temporal lobe epilepsy
Amanda Cano et al.
NANOMEDICINE-NANOTECHNOLOGY BIOLOGY AND MEDICINE (2018)
Mechanisms of epileptogenesis and preclinical approach to antiepileptogenic therapies
Krzysztof Lukawski et al.
PHARMACOLOGICAL REPORTS (2018)
Resveratrol-loaded nanoemulsion prevents cognitive decline after abdominal surgery in aged rats
Fabricio M. Locatelli et al.
JOURNAL OF PHARMACOLOGICAL SCIENCES (2018)
Polyphenols-gut microbiota interplay and brain neuromodulation
Stefania Filosa et al.
NEURAL REGENERATION RESEARCH (2018)
Bioavailable curcumin formulations: A review of pharmacokinetic studies in healthy volunteers
Rohitash Jamwal
JOURNAL OF INTEGRATIVE MEDICINE-JIM (2018)
Inflammation in epileptogenesis after traumatic brain injury
Kyria M. Webster et al.
JOURNAL OF NEUROINFLAMMATION (2017)
Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs
Wolfgang Loscher
NEUROCHEMICAL RESEARCH (2017)
Adjuvant quercetin therapy for combined treatment of epilepsy and comorbid depression
Tanveer Singh et al.
NEUROCHEMISTRY INTERNATIONAL (2017)
ANTICONVULSANT ACTIVITY OF RESVERATROL-LOADED LIPOSOMES IN VIVO
M. S. Ethemoglu et al.
NEUROSCIENCE (2017)
Protective Effect of Resveratrol on the Brain in a Rat Model of Epilepsy
Zhen Li et al.
NEUROSCIENCE BULLETIN (2017)
Epigallocatechin Gallate-Loaded Gelatin-g-Poly(N-Isopropylacrylamide) as a New Ophthalmic Pharmaceutical Formulation for Topical Use in the Treatment of Dry Eye Syndrome
Li-Jyuan Luo et al.
SCIENTIFIC REPORTS (2017)
Establishment of a rhesus monkey model of chronic temporal lobe epilepsy using repetitive unilateral intra-amygdala kainic acid injections
Yajie Chi et al.
BRAIN RESEARCH BULLETIN (2017)
The therapeutic potential of resveratrol: a review of clinical trials
Adi Y. Berman et al.
NPJ PRECISION ONCOLOGY (2017)
Efficient Inhibition of Protein Aggregation, Disintegration of Aggregates, and Lowering of Cytotoxicity by Green Tea Polyphenol-Based Self-Assembled Polymer Nanoparticles
Koushik Debnath et al.
ACS APPLIED MATERIALS & INTERFACES (2016)
Fabrication of an ionic-sensitive in situ gel loaded with resveratrol nanosuspensions intended for direct nose-to-brain delivery
Jifu Hao et al.
COLLOIDS AND SURFACES B-BIOINTERFACES (2016)
Resveratrol prevents oxidative damage and loss of sperm motility induced by long-term treatment with valproic acid in Wistar rats
Giovana M. Ourique et al.
EXPERIMENTAL AND TOXICOLOGIC PATHOLOGY (2016)
Validated LC-MS/MS method for simultaneous quantification of resveratrol levels in mouse plasma and brain and its application to pharmacokinetic and brain distribution studies
Prakash Ramalingam et al.
JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS (2016)
Piperine potentiates the effects of trans-resveratrol on stress-induced depressive-like behavior: involvement of monoaminergic system and cAMP-dependent pathway
Ying Xu et al.
METABOLIC BRAIN DISEASE (2016)
Transient increase of interleukin-1β after prolonged febrile seizures promotes adult epileptogenesis through long-lasting upregulating endocannabinoid signaling
Bo Feng et al.
SCIENTIFIC REPORTS (2016)
Modulation of the Expression of the GABAA Receptor β1 and β3 Subunits by Pretreatment with Quercetin in the KA Model of Epilepsy in Mice -The Effect of Quercetin on GABAA Receptor Beta Subunits-
Sahar Moghbelinejad et al.
JOURNAL OF PHARMACOPUNCTURE (2016)
Resveratrol attenuates cortical neuron activity: roles of large conductance calcium-activated potassium channels and voltage-gated sodium channels
Ya-Jean Wang et al.
JOURNAL OF BIOMEDICAL SCIENCE (2016)
A randomized, double-blind, placebo-controlled trial of resveratrol for Alzheimer disease
R. Scott Turner et al.
NEUROLOGY (2015)
Epigallocatechin Gallate: A Review of Its Beneficial Properties to Prevent Metabolic Syndrome
Samuel Legeay et al.
NUTRIENTS (2015)
Resveratrol Treatment after Status Epilepticus Restrains Neurodegeneration and Abnormal Neurogenesis with Suppression of Oxidative Stress and Inflammation
Vikas Mishra et al.
SCIENTIFIC REPORTS (2015)
Neuroinflammation in Temporal Lobe Epilepsy Measured Using Positron Emission Tomographic Imaging of Translocator Protein
Leah D. Gershen et al.
JAMA NEUROLOGY (2015)
Sirtuin 1 activation enhances the PGC-1α/mitochondrial antioxidant system pathway in status epilepticus
Sheng-Jun Wang et al.
MOLECULAR MEDICINE REPORTS (2015)
Nephroprotective activities of quercetin with potential relevance to oxidative stress induced by valproic acid
Shaista Chaudhary et al.
PROTOPLASMA (2015)
Effects of resveratrol alone or in combination with piperine on cerebral blood flow parameters and cognitive performance in human subjects: a randomised, double-blind, placebo-controlled, cross-over investigation
Emma L. Wightman et al.
BRITISH JOURNAL OF NUTRITION (2014)
Resveratrol in epilepsy: preventive or treatment opportunities?
Merce Pallas et al.
FRONTIERS IN BIOSCIENCE-LANDMARK (2014)
The Potential of Antiseizure Drugs and Agents that Act on Novel Molecular Targets as Antiepileptogenic Treatments
Rafal M. Kaminski et al.
NEUROTHERAPEUTICS (2014)
Understanding the anti-kindling role and its mechanism of Resveratrol in Pentylenetetrazole induced-kindling in a rat model
Lekha Saha et al.
PHARMACOLOGY BIOCHEMISTRY AND BEHAVIOR (2014)
Effect of quercetin and rutin in some acute seizure models in mice
Dorota Nieoczym et al.
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY (2014)
Oxidative stress mediated by NMDA, AMPA/KA channels in acute hippocampal slices: Neuroprotective effect of resveratrol
Andre Quincozes-Santos et al.
TOXICOLOGY IN VITRO (2014)
Polyphenols and the Human Brain: Plant Secondary Metabolite Ecologic Roles and Endogenous Signaling Functions Drive Benefits
David O. Kennedy
ADVANCES IN NUTRITION (2014)
Animal models of epilepsy: use and limitations
Ludmyla Kandratavicius et al.
NEUROPSYCHIATRIC DISEASE AND TREATMENT (2014)
Anti-infective properties of epigallocatechin-3-gallate (EGCG), a component of green tea
J. Steinmann et al.
BRITISH JOURNAL OF PHARMACOLOGY (2013)
Acute neurocognitive effects of epigallocatechin gallate (EGCG)
Andrew Scholey et al.
APPETITE (2012)
Increased In Vivo Expression of an Inflammatory Marker in Temporal Lobe Epilepsy
Jussi Hirvonen et al.
JOURNAL OF NUCLEAR MEDICINE (2012)
Sirtuins as regulators of metabolism and healthspan
Riekelt H. Houtkooper et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2012)
Effects of epigallocatechin-3-gallate on pentylenetetrazole-induced kindling, cognitive impairment and oxidative stress in rats
Tao Xie et al.
NEUROSCIENCE LETTERS (2012)
Pharmacokinetics, oral bioavailability, and metabolic profile of resveratrol and its dimethylether analog, pterostilbene, in rats
Izet M. Kapetanovic et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2011)
Epigallocatechin-3-gallate protects motor neurons and regulates glutamate level
Jixu Yu et al.
FEBS LETTERS (2010)
Dual Beneficial Effects of (-)-Epigallocatechin-3-Gallate on Levodopa Methylation and Hippocampal Neurodegeneration: In Vitro and In Vivo Studies
Ki Sung Kang et al.
PLOS ONE (2010)
Protective Effect of Resveratrol against Kainate-induced Temporal Lobe Epilepsy in Rats
Zheng Wu et al.
NEUROCHEMICAL RESEARCH (2009)
Resveratrol: A natural compound with pharmacological potential in neurodegenerative diseases
Hector I. Rocha-Gonzalez et al.
CNS NEUROSCIENCE & THERAPEUTICS (2008)
Resveratrol increases glutamate uptake, glutathione content, and S100B secretion in cortical astrocyte cultures
Lucia Maria Vieira de Almeida et al.
CELLULAR AND MOLECULAR NEUROBIOLOGY (2007)
Anxiolytic properties of green tea polyphenol (-)-epigallocatechin gallate (EGCG)
Michel Vignes et al.
BRAIN RESEARCH (2006)
(-)-Epigallocatechin gallate attenuates acute stress responses through GABAergic system in the brain
N Adachi et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2006)
Voglibose (Basen (R) AO-128), one of the most important alpha-glucosidase inhibitors
XL Chen et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Mechanism of action of (-)-epigallocatechin-3-gallate: Auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells
Z Hou et al.
CANCER RESEARCH (2005)
SIRT1 functionally interacts with the metabolic regulator and transcriptional coactivator PGC-1α
S Nemoto et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Interleukin-1 beta contributes to the generation of experimental febrile seizures
C Dube et al.
ANNALS OF NEUROLOGY (2005)
Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs.: A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy
W Löscher
EPILEPSY RESEARCH (2002)
Protective effect of resveratrol against intracortical FeCl3-induced model of posttraumatic seizures in rats
YK Gupta et al.
METHODS AND FINDINGS IN EXPERIMENTAL AND CLINICAL PHARMACOLOGY (2001)
Share Paper
